N6-Methyladenosine regulator RBM15B acts as an independent prognostic biomarker and its clinical significance in uveal melanoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.918522
Abstract: Uveal melanoma (UM) is the most frequent intraocular malignant tumor in adults. N6-Methyladenosine (m6A) methylation is recognized as the most critical epigenetic change and is implicated in the development of many malignancies. However, its prognostic… read more here.
Keywords: regulator rbm15b; methyladenosine regulator; independent prognostic; m6a regulators ... See more keywords
RNA N1-methyladenosine regulator-mediated methylation modification patterns and heterogeneous signatures in glioma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.948630
Abstract: N1-methyladenosine (m1A) is ubiquitous in eukaryotic RNA and regulates mRNA translation. However, little is known about its regulatory role in glioma. Here, we identified 4 m1A modification-related patterns based on m1A regulators in the TCGA… read more here.
Keywords: modification; rna methyladenosine; mediated methylation; methyladenosine regulator ... See more keywords